Cue-induced craving for addictive substances has long been known to contribute to the problem of persistent addiction in humans. Research in animals over the past decade has solidly established the central role of dopamine in cue-induced craving for addictive substances, including nicotine. Analogous studies in humans, however, are lacking, especially among African-American smokers, who have lower quit rates than Caucasian smokers. Based on the animal literature, the study's objective was to test the hypothesis that smokers carrying specific variants in dopamine-related genes previously associated with risk for addictive behaviors would exhibit heightened levels of cigarette craving following laboratory exposure to cues. To this end, cigarette craving was induced in healthy AfricanAmerican smokers (n ¼ 88) through laboratory exposure to smoking cues. Smokers carrying either the DRD2 (D2 dopamine receptor gene) TaqI A1 RFLP or the SLC6A3 (dopamine transporter gene) 9-repeat VNTR polymorphisms had stronger cue-induced cravings than noncarriers (Ps o0.05 and 0.01, respectively). Consistent with the separate biological pathways involved (receptor, transporter), carriers of both polymorphisms had markedly higher craving responses compared to those with neither (Po0.0006), reflecting additive effects. Findings provide support for the role of dopamine in cue-induced craving in humans, and suggest a possible genetic risk factor for persistent smoking behavior in African-American smokers. Keywords: smoking; cues; craving; nicotine; dopamine; DRD2; SLC6A3; polymorphism Despite the widely recognized risks, about one-third of the world's adult population continues to smoke cigarettes.
Despite the widely recognized risks, about one-third of the world's adult population continues to smoke cigarettes. 1 According to estimates from the US, a majority of smokers attempt to quit, but only a small minority are able to maintain long-term abstinence. 2 Recent population-based data have indicated that the problem of long-term abstinence is particularly salient for African-American smokers. 3 While the prevalence of cigarette smoking among African Americans is comparable to that of Caucasians, survey data indicate that African-American smokers have markedly lower quit rates. 3 In spite of these figures, African Americans have been understudied in research on persistent smoking behavior. 4, 5 There is thus clearly a need, both in general and regarding African-American smokers in particular, to better understand factors that may contribute to persistent smoking behavior.
Early twin studies demonstrated that persistent smoking behavior (ie difficulty remaining abstinent) has a substantial genetic component. 6 Providing additional support for a genetic contribution, studies over the past decade have identified two specific genetic polymorphisms in the dopamine system related to cigarette smoking behavior, as well as other types of substance abuse. [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] The presence of the TaqI RFLP A1 allele of the D2 dopamine receptor gene (DRD2), first found to be related to severe alcoholism, 7 has more recently been reported to be related to cigarette smoking, [9] [10] [11] as well as other addictive behaviors (eg Persico et al 16 ; see Noble 12 for a review). Some studies, however, have failed to replicate these findings, [17] [18] while others have suggested that the magnitude of relations between the A1 allele and addictions may vary by sample characteristics. [19] [20] The biological plausibility of a link between this polymorphism at DRD2 and addictive behaviors is supported by numerous molecular studies (see Noble 12 for a review), indicating that the presence of the A1 allele is associated with lower D2 receptor density and reduced CNS dopaminergic function. These basal deficits are thought to potentiate the incentive salience of triggers (eg cues/reminders) for addictive behaviors, including smoking, which in turn, induce acute phasic increases in dopamine levels. 12, 21 The second specific polymorphism in the dopamine pathway associated with smoking behavior is a 9-repeat variable number of tandem repeats (VNTR) sequence in the 3 0 untranslated region of the dopamine transporter gene (SLC6A3). The presence of this 9-repeat allele, first associated with severe alcohol problems, 13, 14 has also subsequently been reported to be related to cigarette smoking behavior. 15 On the other hand, the absence of the 9-repeat allele was reported in another study to be related to smoking status, 22 while a third study 23 found no relations. The biological plausibility of a link between this VNTR and smoking behavior is supported by several recent studies, demonstrating that the presence of the SLC6A3 9-repeat allele is associated with enhanced transcription of the dopamine transporter protein (eg Michelaugh et al 24 ), possibly resulting in overly efficient clearing of synaptic dopamine, and, in turn, lower basal availability. Similar to the DRD2-A1 allele, the 9-repeat polymorphism might thus enhance the incentive salience of smoking cues thought to trigger acute increases in dopamine levels.
One possible reason for the somewhat mixed findings in the literature attempting to relate these dopamine polymorphisms to smoking behavior may be the lack of experimental control over the multiplicity of factors that influence smoking behavior in real-world settings. 25 In addition, differences in operational definitions of smoking behavior among the studies could have impacted results. 15 One approach to addressing these concerns is to examine specific genetic influences on more tightly characterized smoking-related endophenotypes. One potentially important endophenotype is cue-induced cigarette craving. The utility of examining genetic influences on this more proximal phenotype is supported by research demonstrating that cue-induced craving and drug seeking in animal models is the pre-eminent pathway by which dopamine subserves addictive behaviors (see Berridge and Robinson 26 for a review). For example, seminal studies by Gratton and Wise 27 and Kiyatkin et al 28 found that exposing rats to cues that signal the availability of an addictive substance induces significant drug seeking responses (putatively via the operation of classical conditioning), and that dopamine availability mediated these responses. A growing literature has provided additional compelling evidence supporting these findings (see Berridge and Robinson 26 for an extensive review of this literature).
In human studies, cigarette craving induced by exposure to smoking cues has been identified, both by clinical accounts and by empirical studies, to be a strong predictor of persistent smoking, as well as other addictive behaviors. 29, 30 That is, exposures to cues (eg the sight of a cigarette) throughout the day are thought to trigger repeated experiences of high levels of craving, making it particularly difficult for people who are trying to quit smoking to stay abstinent. In one study of humans, 31 carriers of a specific polymorphism at DRD4 were reported to have higher levels of cue-induced cigarette cravings than noncarriers, although relations between that polymorphism and addictive behaviors have yet to be established. 32, 33 Based on the literature reviewed above, the present study focused on African-American smokers and used an experimental model of cue-induced craving to test the hypothesis that carriers of the DRD2 TaqI RFLP A1 (D2 dopamine receptor) or the SLC6A3 VNTR 9-repeat (dopamine transporter) polymorphisms would exhibit heightened levels of cigarette craving induced by laboratory exposure to cues. Furthermore, smokers found to be carriers of both the receptor and transporter polymorphisms were hypothesized to exhibit the strongest cue-induced craving reactions.
Method

Overview
To test the study hypotheses, 88 African-American current smokers underwent a laboratory cue exposure session, during which they were exposed to scriptguided mental imagery of both smoking and neutral stimuli. Measures of cigarette craving were taken immediately before and after each imagery session. All participants were genotyped for the DRD2 A1 and SLC6A3 9-repeat polymorphisms. A factorial analysis of variance, with carrier status of each polymorphism entered as predictors, was used to assess effects of genotype on cue-induced cigarette craving.
Participants
Smokers (n ¼ 88) were recruited by advertisement from the East Harlem community in New York City to participate in a research study. Participants had to: speak English, be at least 23 years old (to increase the likelihood of recruiting regular daily smokers), have no previous or current cancer, cardiovascular disease, emphysema, or other smoking-related illnesses, not be currently attempting to quit smoking, and report no history of treatment for other substance abuse. All participants provided informed consent prior to participation in the study, and all study procedures were approved by the Mount Sinai Medical Center's Institutional Review Board.
Measures
Background questionnaires Participants completed demographic (age, gender, education level, income level) and smoking history (cigarettes per day, years of smoking) questionnaires. In addition, participants completed two standardized indices, the Fagerstrom Test of Nicotine Dependence (FTND), which assesses habit strength, 34 and the Minnesota Nicotine Withdrawal Questionnaire (MNWQ), which assesses strength of withdrawal symptoms. 35 Both instruments have been used extensively in the literature and have strong psychometric properties. 34, 35 Participants also completed a face valid, four-item, 0-25 scale of imagery vividness (eg How vivid were your images?) to assess how well they were able to image the smoking and neutral stimuli.
Outcome measure A five-item 0-100 craving questionnaire was used to assess craving before and after each of the imagery scenes. The instrument assesses craving using a variety of descriptors, including 'urge,' 'desire,' and 'craving', 36 has been employed in a number of laboratory cravinginduction studies (eg Hutchison et al 37 ) , and was highly reliable in the current sample (Chronbach's alpha for each of the four administrations ranged from 0.96-0.98).
Procedure
After providing informed consent, participants donated 5 ml of blood (double-blinded) for genotyping and completed background questionnaires. They then participated in a classic laboratory smoking cueinduced craving paradigm, 29 which included imaginal exposure to both neutral (changing a light bulb) and smoking (lighting up after a meal) stimuli. Briefly, participants were asked to close their eyes and imagine as vividly as possible the two separate scripted scenarios, which were read to them by an examiner. The scenarios (neutral, smoking) were read for 60 s and were followed by 30 s of 'quiet time' during which participants were instructed to continue to imagine the scenes. The neutral imagery was always administered first and the smoking imagery second, to avoid possible carryover effects. To further control carryover, participants viewed a nature video for 5 min between the imagery scenes. Immediately before and after exposure to each imagery scene, participants completed the craving scale. In addition, after each of the imagery scenes, participants completed the vividness scale. All participants smoked one of their own cigarettes immediately before the study session was begun to reduce variability in initial deprivation levels and to avoid acute ceiling effects in craving at the preimagery assessment point. Pilot data indicated that without this instruction to smoke prior to the session, by the time participants completed the questionnaires and reached the cue-induced craving paradigm (about 20 min), many had levels of craving nearing the top of the 0-100 scale. After completing the study, participants were reimbursed $50 for their time and thanked for their participation.
Data analysis
To assess for genotype, leukocyte DNA was isolated from blood samples using the Puregene DNA isolation kit (Gentra Systems, Minneapolis, MN, USA). The two loci evaluated were genotyped by previously described PCR methodologies using published primer sequences 38, 39 :
Amplification was performed under standard conditions and PCR products were resolved by electrophoresis through 1.5% agarose gels with appropriate size standards and visualized by staining with ethidium bromide. SLC6A3 alleles were resolved directly and ranged in size from 200-to 520-bp. DRD2 allele amplicons were digested with 5 U of TaqI (New England Biolabs, Beverly, MA, USA) overnight and the digestion products were resolved by electrophoresis. Quality control methods for the genotyping included blinded scoring of alleles by two individuals and repeat genotyping of a small number of samples to ensure reproducibility.
To examine the study hypotheses, pre-post imagery change scores were calculated as an index of craving reactivity to the imagery conditions. Following classic methods in the literature, 40 ,41 preimagery scores were included as a covariate to control for 'baseline' variability, yielding baseline-adjusted change scores. Change scores were used not only to control for baseline levels, but to avoid multiple comparisons and their attendant inflation of Type I error probability that would be necessitated in a repeated measures approach. 41 These outcomes were then assessed using factorial analyses of variance (ANO-VA), entering DRD2 and SLC6A3 genotype status (presence vs absence) as predictors, and baseline (preimagery) craving and neutral reactivity scores (both preimagery and change, as above) as covariates, to rule out the possibility that reactivity differences may be due to baseline differences, or imagery per se. In addition, we conducted preliminary analyses to examine relations between demographic/smoking variables, group status and reactivity.
Results
Sample characteristics
About two-thirds of the sample were female, 45% had some posthigh school education, and 40% reported household income levels of greater than $20 000/year. The mean age of the sample was 41.779.1 years. Participants had smoked an average of 20.578.8 cigarettes per day for an average of 21.579.6 years.
For descriptive purposes, allele frequencies for the two genes can be found in Table 1 , and were found to be comparable to those reported previously 38, 42, 43 in samples of African Americans. Consistent with previous studies (eg Blum et al 7 and Lerman et al 22 ), 'carriers' were defined as participants who tested positive for the presence of the allelic variants, Cue-induced cigarette craving J Erblich et al whether homozygous or heterozygous (ie A1/A1 and A1/A2 for DRD2; 9R/* and 9R/9R for SLC6A3). Using this definition, we found that 56% of the sample (n ¼ 49) carried the DRD2-A1 allele (n ¼ 10 homozygous), while 44% (n ¼ 39) did not (ie A2/A2). For the SLC6A3 VNTR allele, 29.5% of the sample (n ¼ 26) carried the 9-repeat allele (n ¼ 2 homozygous), while the remaining 70.5% (n ¼ 62) did not (see Table 2 ). Owing to the small sample size, we were unable to explore potential differences between homo-and heterozygotes. Genotype frequencies in this sample demonstrated Hardy-Weinberg equilibrium.
To assess the possibility of genotype differences in background variables, we compared the demographic and smoking characteristics by each genotype. As shown in Table 3 , SLC6A3-9 repeat carriers smoked for an average of 4 fewer years than noncarriers and had higher vividness scores after the smoking imagery. DRD2-A1 carriers were marginally significantly more likely to report lower education levels than noncarriers. No other differences between groups on background variables were found. We then examined relations between these background variables and craving reactions. Not surprisingly, results revealed a moderately strong correlation between the vividness of the smoking imagery and craving reactions (r ¼ 0.41; Po0.0001). No other background variables were significantly related to craving reactions (Ps40.1).
Genotype effects on craving reactions
A preliminary t-test confirmed that the smoking imagery induced significant craving reactions (raw mean change ¼ 21.773.9); t 87 ¼ 5.5, Po0.0001. Consistent with the study hypothesis, the ANOVA revealed a significant effect of carrier status on smoking cue-induced craving reactions. As depicted in Figure 1 , carriers of the DRD2 (receptor) A1 allele had smoking-cue-induced craving reactions that were significantly higher than those of noncarriers; F 1/87 ¼ 4.5, Po0.05. Similarly, carriers of the SLC6A3 (transporter) 9-repeat allele had cue-induced craving reactions almost twice as great as noncarriers; F 1/87 ¼ 6.4, Po0.01. As baseline craving levels and reactivity to neutral imagery were entered as covariates, the genetic effects observed here were specific to smoking-cue-induced craving, rather than to any differences in baseline craving or reactivity to imagery per se.
The interaction between DRD2-A1 and SLC6A3-9R carrier statuses was not significant; F 1/87 ¼ 0.05, Po0.9. Thus, the statistical analyses did not support the presence of a gene-gene interaction. The data did, however, support additive relations between carrier status of both polymorphisms (which are thought to have distinct biological effects) and the magnitude of smoking-cue-induced craving. Consistent with the study hypothesis, planned contrasts of the four genotype subgroups (À/À, þ /À, À/ þ , þ / þ ) revealed that individuals who carried both the DRD2 (D2 receptor) A1 and SLC6A3 (transporter) 9-repeat variants exhibited the highest smoking cue-induced craving reactions, reaching levels that were almost five times higher than carriers of neither variant (t 107 ¼ 3.6, Po0.0006), while carriers of one of the two variants had intermediate craving reactions (see Figure 2) . Inclusion of the demographic and smoking characteristics (Table 3) as covariates yielded an identical pattern of significant results, further confirming that findings were not due to any background differences between carriers and noncarriers.
Discussion
Consistent with the study hypotheses, the present results provide the first evidence of higher smoking cue-induced craving among African-American smokers who are carriers of genetic polymorphisms previously demonstrated to be related to smoking behavior in large-scale survey studies. Moreover, polymorphisms for presynaptic (transporter) and postsynaptic (D2 receptor) elements in dopamine pathways were found to have an additive impact on cue-induced craving, with carriers of both having five-fold higher reactions. Findings are consistent with previous research 31 that identified higher levels of cue-induced craving among 20 carriers of a specific allele (a 7-repeat VNTR) at DRD4, compared to noncarriers (n ¼ 48), in a predominantly Caucasian sample. Together with previous results, the present study provides further support for the role of dopamine in cue-induced craving and suggests a possible behavioral mechanism underlying relations between these genetic polymorphisms and persistent smoking behavior previously observed in survey studies.
The results of this initial study with a sample of 88 African-American smokers raises the possibility that the effects of these polymorphisms could contribute to difficulty quitting. Some initial support for this possibility comes from a study, which found fewer successful quitters among African-American smokers carrying the 6-, 7-, or 8-repeat VNTR polymorphisms at DRD4, compared to Caucasians. 33 It is important to note that this study did not compare African-American smokers to smokers with other racial/ethnic backgrounds, so the results do not provide an direct explanation for differential quit rates across racial/ ethnic groups. Future prospective studies of cueinduced craving with an expanded set of candidate genotypes in more diverse samples of smokers are now clearly warranted. Indeed, according to some reports (eg Kang et al 43 ), the frequency of the SLC6A3 9-repeat allele may be more common in Caucasians (0.27-0.29) than in African Americans (0.15-0.22), while the reverse has been observed for DRD2-A1 (0.36 for African Americans vs 0.19 for Caucasians), so additional research with endophenotypes explored across racial/ethnic groups is clearly needed.
In contrast to the more equivocal findings reported in the literature with respect to broad phenotypes (eg smoking status), which are subject to greater imprecision, the use of specific endophenotypes in this research may have contributed to the relatively strong results seen here. Indeed, a complex behavior such as smoking is likely to have multiple etiologies with different pathways being more or less important for different smokers, or under different circumstances. 44 Results of the present study suggest the utility of employing more narrowly defined phenotypes, or endophenotypes, under controlled conditions when attempting to determine mechanisms underlying complex behavioral problems such as persistent smoking behavior. Further studies will be necessary to fully elucidate the CNS pathways linking genotype to cue-induced craving. Ultimately, such research may provide critical insights into the mechanisms responsible for the persistence of smoking and other addictions, as well as how to develop interventions targeted to individuals whose genotypes may make them susceptible.
We should also emphasize that we cannot formally rule out the possibility that the polymorphisms studied here, rather than having a direct impact, are in linkage disequilibrium with other genotypes that, in turn, may more directly affect cue-induced craving. Recent attempts to identify such genotypes in relation to smoking behavior more generally, however, have met with little success. 42 The present results suggest the importance of examining potential additive effects, as well as gene-gene interactions, and other modifiers of genotype effects. Although we cannot formally rule out effects of population subgroup stratification in the present study, it has been established that such effects are extremely unlikely for cue-induced craving. 31 As there could conceivably be modifying effects of race/ethnicity, the present findings from a sample of African-American smokers need to be replicated in other samples to confirm the generalizability of effects. Finally, it should be emphasized that this study only employed one smoking cue, script-guided imagery. The strength of genetic effects on reactions to other types of cues and/ or modalities (eg smell) remains to be determined.
Further studies of relations between dopamine polymorphisms and cue-induced craving exhibited in experimental models with humans may ultimately help in the design and testing of novel pharmacogenetic approaches to smoking cessation, as well as other addictions. Indeed, several studies (eg Swan 44 and Caskey et al 45, 46 ) have found that administration of dopamine agonists (bromocriptine) and antagonists (haloperidol) modulates smoking behavior. An important next step in this line of research would be to determine if these changes are further modified by genotype, and whether agonist/antagonist administration has an impact on modulating cravings.
It should also be emphasized that while these dopamine polymorphisms were found to be related to cue-induced cigarette craving, there are clearly other pathways to persistent smoking and the persistence of other addictive behaviors (eg Swan 44 ). One pathway of particular interest is the effects of stress on cigarette craving, which we have recently found to be related to dopamine polymorphisms in a larger, more heterogeneous sample. 47 Results of the present study underscore the importance of continued characterization of the functions of DRD2-A1 and SLC6A3-9R, as well as further examination of other polymorphisms in the dopamine system not yet established to be associated with smoking variables (eg other polymorphic loci at DRD2; loci at DRD4). Naturalistic investigations of craving reactions in the daily life of carriers of these dopamine polymorphisms may also be important next steps in further elucidating the increasingly welldocumented role of genetic factors in smoking behavior and addiction, more generally.
